CClinicalTrials.gg
CompletedNCT00164515PEPUpdated Jul 26, 2019

Increasing Physical Activity Among Overweight Women With Mobility Disabilities.

A Phase 2 interventional study of Personalized exercise programme (PEP) in Obesity, sponsored by Centers for Disease Control and Prevention. Completed at 1 site in United States. Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2019-07-26.

Sponsored by Centers for Disease Control and Prevention · Phase 2, Interventional, and Treatment

Phase
Phase 2
Study type
Interventional
Enrollment
96
Allocation
Randomized
Ages
18 Years to 75 Years
Sex
All
01

Study summary

This study aims to increase physical activity among overweight African-American women with mobility limitations.

Read the detailed description

Regular, sustainable physical activity can have a dramatic effect on reducing obesity and other secondary conditions and increasing quality of life. People with mobility limitations have a higher level of physical inactivity resulting from numerous personal and environmental barriers to physical activity participation. This project will evaluate the feasibility of increasing physical activity among overweight individuals with mobility limitations through physician-referrals to a personalized exercise programme at the Chicago-based National Center on Physical Activity and Disability (NCPAD).

02

Conditions studied

  • Obesity

Keywords

  • obesity, mobility limitations, women, physical activity
03

In context

Overweight

3,670 studies on the registry are indexed under Overweight; 849 are open to participants now.

This study's enrollment of 96 is above the median of 73 across 3,175 interventional studies indexed under Overweight.

Browse Overweight studies →

Lead sponsor

Centers for Disease Control and Prevention is the lead sponsor of 273 studies on the registry; 2 are open to participants now.

Of its 11 completed or terminated interventional studies of FDA-regulated products, 8 (73%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • 18 years or older
  • English speaking
  • Self-reported mobility limitation
  • BMI greater than or equal to 27
  • Receiving care at the University of Illinois, Chicago (UIC) Medical Center
  • Sedentary

Exclusion criteria

Exclusion Criteria:

  • did not receive physician approval to participate
05

Study design

Phase
Phase 2
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
96 participants (actual)

Study arms

  • No intervention
    Arm 1: Physical activity awareness

    The awareness group received a physician-recommendation to exercise an informational brochure, and pedometer.

  • Experimental
    Arm 2: Lower Support

    The lower support group received arm 1 plus monthly newsletter, weekly personalized exercise support via telephone.

    Behavioral: Personalized exercise programme (PEP)

  • Experimental
    Arm 3: Higher support

    The higher support group received arm 1 plus arm 2 plus a face-to-face monthly exercise support group.

    Behavioral: Personalized exercise programme (PEP)

Interventions

  • BehavioralPersonalized exercise programme (PEP)

    Physician referred overweight and obese clients to 24 month personalized exercise programme at the U. of Illinois, Chicago

    Also known as: PEP

06

What researchers measure

Primary outcomes

  1. Physical activity

    Physical activity was assessed using the Physical Activity and Disability Scale (PADS), the Barriers to Physical Activity and Disbility Scale (B-PADS), (Rimmer et al 2000) and the Mobility Limitation score (Velozo et al 1999).

    Time frame: 24 months

  2. Body mass index (BMI)

    Derived emperically

    Time frame: 24 months

  3. Blood lipids

    Derived emperically

    Time frame: 24 months

  4. Weight

    Derived emperically

    Time frame: 24 months

  5. Blood Pressure

    Dervied emperically

    Time frame: 24 months

Secondary outcomes

  1. Psychosocial Health

    Confirmed using the Quality of Wellbeing scale (Anderson et al 1989), and CARDIA-2 scale, an 11-item assessment (Allen et al 2001).

    Time frame: 24 months

07

Study locations

1 site
  • University of Illinois, Chicago
    Chicago, Illinois 60612, United States
08

References and documents

Publications

  • Rimmer JH, Rauworth A, Wang E, Heckerling PS, Gerber BS. A randomized controlled trial to increase physical activity and reduce obesity in a predominantly African American group of women with mobility disabilities and severe obesity. Prev Med. 2009 May;48(5):473-9. doi: 10.1016/j.ypmed.2009.02.008. PubMed 19459233 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 26, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT00164515
Lead sponsor
Centers for Disease Control and Prevention
Collaborators
University of Illinois, Center on Health Promotion Research for Persons with Disabilities
Responsible party
Sponsor
First posted
Sep 14, 2005
Start date
Oct 2004
Primary completion
Oct 2007
Completion
Oct 2007
Last update
Jul 26, 2019

Study contacts

James Rimmer, Ph.D.
principal investigator · UIChicago

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion